Drug delivery devices are used for administration of drug compounds in effective ways. Implantable ports, also called portacaths or subcutaneous ports, are used to administer chemotherapy, medicine, fluids, and nutrients, or take blood samples. GlobalData uses proprietary data and analytics to provide a comprehensive report on the implantable ports market in Israel. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the implantable ports market in Israel was AngioDynamics followed by B. Braun Melsungen, Becton Dickinson and Co and Teleflex.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
An Implantable port consists of a catheter with a small reservoir (port) attached to it. This market covers both double lumen and single lumen implantable ports. A double lumen port is a port with two access points. A single lumen port is a port with one access point.
The implantable ports market in Israel can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size implantable ports in Israel, buy the report here.